Similar articles

• Comparative study of the clinical effect of acenocoumarol (Sintrom) and phenprocoumon (Marcoumar) in myocardial infarction and angina pectoris.

  Fekkes N, de Jonge H, Veltkamp JJ, Bieger R, Loeliger EA. Fekkes N, et al. Acta Med Scand. 1971 Dec;190(6):535-40. doi: 10.1111/j.0954-6820.1971.tb07471.x. Acta Med Scand. 1971. PMID: 5149098 Clinical Trial. No abstract available.
• [Clinical use of heparin-heparinoid-mixtures].

  Hörder MH, Stier WD, Brunswig D. Hörder MH, et al. Arzneimittelforschung. 1969 Nov;19(11):1873-6. Arzneimittelforschung. 1969. PMID: 4190000 German. No abstract available.
• [Oral anticoagulation with vitamin K antagonists].

  Alberio L. Alberio L. Ther Umsch. 2003 Jan;60(1):5-9. doi: 10.1024/0040-5930.60.1.5. Ther Umsch. 2003. PMID: 12638470 Review. German.
• Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands.

  Zhang Y, de Boer A, Verhoef TI, van der Meer FJ, Le Cessie S, Maitland-van der Zee AH; EU-PACT group; members of the EU-PACT group are. Zhang Y, et al. Thromb Res. 2015 Jul;136(1):94-100. doi: 10.1016/j.thromres.2015.04.034. Epub 2015 May 2. Thromb Res. 2015. PMID: 25971661
• Implications of anticoagulant therapy.

  Ellison N, Jobes DR, Schwartz AJ. Ellison N, et al. Int Anesthesiol Clin. 1982 Winter;20(4):121-35. Int Anesthesiol Clin. 1982. PMID: 6757142 Review. No abstract available.